JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2004; 44:2166-2172, doi:10.1016/j.jacc.2004.08.054
© 2004 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nanthakumar, K.
Right arrow Articles by Lee, D. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nanthakumar, K.
Right arrow Articles by Lee, D. S.

ELECTROPHYSIOLOGY AND HEART FAILURE: VIEWPOINT

Prophylactic implantable cardioverter-defibrillator therapy in patients with left ventricular systolic dysfunction

A pooled analysis of 10 primary prevention trials

Kumaraswamy Nanthakumar, MD*,*, Andrew E. Epstein, MD{ddagger}, G. Neal Kay, MD{ddagger}, Vance J. Plumb, MD{ddagger} and Douglas S. Lee, MD{dagger}

* Division of Cardiology, University Health Network
{dagger} Institute for Clinical Evaluative Sciences, University of Toronto, Toronto, Ontario, Canada
{ddagger} University of Alabama at Birmingham, Birmingham, Alabama

Manuscript received April 29, 2004; revised manuscript received August 9, 2004, accepted August 16, 2004.

* Reprint requests and correspondence: Dr. Kumaraswamy Nanthakumar, Division of Cardiology, University Health Network, Toronto General Hospital, 150 Gerrard Street West, PMCC 3-558, Toronto, Ontario, Canada M5G 2C4 (Email: nanthaj{at}yahoo.com).

Strategies to decrease sudden cardiac death in patients with left ventricular systolic dysfunction are evolving. Recent clinical trials have evaluated the role of prophylactic implantable cardioverter-defibrillators (ICDs) in patients with and without additional risk stratifiers. We pooled studies comparing treatment with and without ICDs from published data and presented abstracts, irrespective of QRS duration and etiology of systolic dysfunction. On the basis of the available clinical trials, implantation of an ICD for primary prevention of death provides a 7.9% absolute mortality reduction (p = 0.003) in patients with left ventricular (LV) systolic dysfunction who were receiving optimized medical therapy. This finding was not sensitive to the exclusion of any individual trial. The ICD is an effective primary preventative measure in patients who are at risk for death; however, the application of this therapy needs to be individualized for the patient, similar to drug therapies in LV systolic dysfunction. In health care settings without unlimited resources, optimal use of this therapy will require better risk stratification methods or lowering of the initial device cost.

Abbreviations and Acronyms
  ACE = angiotensin-converting enzyme
  AMIOVIRT = Amiodarone Versus Implantable Cardioverter-Defibrillator Randomized Trial
  CABG-Patch = Coronary Artery Bypass Graft Patch trial
  CAT = Cardiomyopathy Trial
  CI = confidence interval
  COMPANION = Comparison of Medical Therapy, Pacing, and Defibrillation in Patients With Left Ventricular Systolic Dysfunction trial
  CRT = cardiac resynchronization therapy
  DEFINITE = Defibrillators In Non-Ischemic Cardiomyopathy Treatment Evaluation trial
  DINAMIT = Defibrillator In Acute Myocardial Infarction Trial
  EP = electrophysiology
  ICD = implantable cardioverter-defibrillator
  LV = left ventricular
  MADIT = Multicenter Automatic Defibrillator Implantation Trial
  MUSTT = Multicenter Unsustained Tachycardia Trial
  RR = relative risk
  SCD-HeFT = Sudden Cardiac Death in Heart Failure Trial




This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
A. E. Epstein, J. P. DiMarco, K. A. Ellenbogen, N.A. M. Estes III, R. A. Freedman, L. S. Gettes, A. M. Gillinov, G. Gregoratos, S. C. Hammill, D. L. Hayes, et al.
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons
J. Am. Coll. Cardiol., May 27, 2008; 51(21): e1 - e62.
[Full Text] [PDF]


Home page
CirculationHome page
A. E. Epstein, J. P. DiMarco, K. A. Ellenbogen, N.A. M. Estes III, R. A. Freedman, L. S. Gettes, A. M. Gillinov, G. Gregoratos, S. C. Hammill, D. L. Hayes, et al.
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons
Circulation, May 27, 2008; 117(21): e350 - e408.
[Full Text] [PDF]


Home page
BMJHome page
S. K H Lam and A. Owen
Combined resynchronisation and implantable defibrillator therapy in left ventricular dysfunction: Bayesian network meta-analysis of randomised controlled trials
BMJ, November 3, 2007; 335(7626): 925 - 925.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
J. Camm, H. Klein, and S. Nisam
The cost of implantable defibrillators: perceptions and reality
Eur. Heart J., February 2, 2007; 28(4): 392 - 397.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
P. Kirchhof, G. Breithardt, and L. Eckardt
Primary prevention of sudden cardiac death.
Heart, December 1, 2006; 92(12): 1873 - 1878.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. G. Assomull, S. K. Prasad, J. Lyne, G. Smith, E. D. Burman, M. Khan, M. N. Sheppard, P. A. Poole-Wilson, and D. J. Pennell
Cardiovascular Magnetic Resonance, Fibrosis, and Prognosis in Dilated Cardiomyopathy
J. Am. Coll. Cardiol., November 21, 2006; 48(10): 1977 - 1985.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death)
J. Am. Coll. Cardiol., September 5, 2006; 48(5): e247 - e346.
[Full Text] [PDF]


Home page
EuropaceHome page
Writing Committee Members, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al.
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Europace, September 1, 2006; 8(9): 746 - 837.
[Full Text] [PDF]


Home page
Eur Heart J SupplHome page
E. Vanoli and P. B. Adamson
What does the future hold for the management of chronic heart failure?
Eur. Heart J. Suppl., June 1, 2006; 8(suppl_C): C51 - C57.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
W. C. Levy, D. Mozaffarian, D. T. Linker, S. C. Sutradhar, S. D. Anker, A. B. Cropp, I. Anand, A. Maggioni, P. Burton, M. D. Sullivan, et al.
The Seattle Heart Failure Model: Prediction of Survival in Heart Failure
Circulation, March 21, 2006; 113(11): 1424 - 1433.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. A. Ellenbogen, M. A. Wood, and H. U. Klein
Why Should We Care About CARE-HF?
J. Am. Coll. Cardiol., December 20, 2005; 46(12): 2199 - 2203.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
E. G. Manios, E. M. Kallergis, E. M. Kanoupakis, H. E. Mavrakis, D. C. Kambouraki, D. A. Arfanakis, and P. E. Vardas
Amino-Terminal Pro-Brain Natriuretic Peptide Predicts Ventricular Arrhythmogenesis in Patients With Ischemic Cardiomyopathy and Implantable Cardioverter-Defibrillators
Chest, October 1, 2005; 128(4): 2604 - 2610.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
Authors/Task Force Members, K. Swedberg, Writing Committee:, J. Cleland, H. Dargie, H. Drexler, F. Follath, M. Komajda, L. Tavazzi, O. A. Smiseth, et al.
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology
Eur. Heart J., June 1, 2005; 26(11): 1115 - 1140.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
S. G. Pauker, N. A. M. Estes, and D. N. Salem
Preventing Sudden Cardiac Death: Can We Afford the Benefit?
Ann Intern Med, April 19, 2005; 142(8): 664 - 666.
[Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2004 by the American College of Cardiology Foundation.